A Study of Intravenous Formulation of Guselkumab Using Prefilled Syringes and Final Vialed Product in Healthy Participants
Clinical trial NCT04617691 · COMPLETED
Trial details
- NCT number
- NCT04617691
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2021-07-20
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.